Caliway Overview
Company Headquarters: New Taipei City, Taiwan
Founded: 2012
Workforce: <25
Company Working: Caliway is a clinical stage biopharmaceutical company which is involved in development of innovative therapeutics in the treatment of obesity and anti-aging disorders. The company developing small molecule for non-surgical fat reduction, Dercum’s disease, cellulite, lipoma, osteoarthritis, and others. Moreover, the company pipeline molecule CBL-514, is a first-in-class new drug which can activate adipocyte apoptosis at the injection site and efficiently reduce the subcutaneous fat without any serious side effects. The company has strong business presence in Taiwan.
Strategy
Caliway focused on the development of medical aesthetics and inflammatory medicine discovery of small-molecule therapeutics. The company emphasizes on improving patient health-related quality of life globally. Moreover, the company strategizes is to improve its R&D facility for the development of small molecules. The company is utilizing various technologies to provide advanced therapeutics. It also offers customized, medical aesthetic and inflammatory disease medicines.
